Testing effectiveness (Phase 2)Study completedNCT00694161
What this trial is testing
The Effects Of Fx-1006A On Transthyretin Stabilization And Clinical Outcome Measures In Patients With V122I Or Wild-Type TTR Amyloid Cardiomyopathy
Who this might be right for
Cardiomyopathy
Pfizer 35